# Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects

> **NCT00789126** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** VX-509

## Key facts

- **NCT ID:** NCT00789126
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2009-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789126, "Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00789126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*